These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 19273542)
1. Enzymuria determination in children treated with aminoglycosides drugs. Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Seyed-Ebrahimi A; Ghasemi A; Jabari E Hum Exp Toxicol; 2008 Dec; 27(12):879-82. PubMed ID: 19273542 [TBL] [Abstract][Full Text] [Related]
2. Proximal tubule damage in patients treated with gentamicin or amikacin. Wiland P; Szechciński J Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723 [TBL] [Abstract][Full Text] [Related]
3. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859 [TBL] [Abstract][Full Text] [Related]
4. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)]. Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703 [TBL] [Abstract][Full Text] [Related]
5. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics. Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430 [TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs. Naruse T; Hirokawa N; Oike S; Maekawa T Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185 [TBL] [Abstract][Full Text] [Related]
7. Urinary excretion rates of multiple renal indicators after kidney transplantation: clinical significance for early graft outcome. Matteucci E; Carmellini M; Bertoni C; Boldrini E; Mosca F; Giampietro O Ren Fail; 1998 Mar; 20(2):325-30. PubMed ID: 9574459 [TBL] [Abstract][Full Text] [Related]
8. N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs. Wiland P; Szechiński J Arch Immunol Ther Exp (Warsz); 1994; 42(4):331-6. PubMed ID: 7487376 [TBL] [Abstract][Full Text] [Related]
9. Mercury in dental restoration: is there a risk of nephrotoxicity? Mortada WL; Sobh MA; El-Defrawy MM; Farahat SE J Nephrol; 2002; 15(2):171-6. PubMed ID: 12018634 [TBL] [Abstract][Full Text] [Related]
10. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes. Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE J Urol; 2007 Aug; 178(2):640-6. PubMed ID: 17574624 [TBL] [Abstract][Full Text] [Related]
11. Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage? Nakayama H; Echizen H; Gomi T; Shibuya Y; Nakamura Y; Nakano K; Arashi H; Itai T; Ohnishi S; Tanaka M; Orii T Ther Drug Monit; 2009 Feb; 31(1):126-30. PubMed ID: 19125150 [TBL] [Abstract][Full Text] [Related]
12. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity. Assadamongkol K; Tapaneya-Olarn W; Chatasingh S J Med Assoc Thai; 1989 Jan; 72 Suppl 1():42-6. PubMed ID: 2732646 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats. Palla R; Paternoster G; Galigani P; Giovannini L; Bertelli AA; Romano MR; Alessandrì MG; Bertelli A Drugs Exp Clin Res; 1987; 13(12):751-6. PubMed ID: 3447879 [TBL] [Abstract][Full Text] [Related]
14. Urinary phospholipids excretion in neonates treated with amikacin. Ibrahim S; Langhendries JP; Bernard A; Tulkens PM Int J Clin Pharmacol Res; 1994; 14(5-6):149-56. PubMed ID: 7672871 [TBL] [Abstract][Full Text] [Related]
15. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model]. Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687 [TBL] [Abstract][Full Text] [Related]
16. The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis. Glass S; Plant ND; Spencer DA J Cyst Fibros; 2005 Dec; 4(4):221-5. PubMed ID: 16239129 [TBL] [Abstract][Full Text] [Related]
17. Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy. Gluhovschi G; Gadalean F; Gluhovschi C; Velciov S; Petrica L; Bob F; Bozdog G; Kaycsa A Ren Fail; 2014 May; 36(4):534-40. PubMed ID: 24456153 [TBL] [Abstract][Full Text] [Related]
18. Role of urinary tubular enzymes in evaluation of children with ureteropelvic junction narrowing under conservative management. Shokeir AA; Taha MA Urology; 2009 May; 73(5):1016-20. PubMed ID: 19394498 [TBL] [Abstract][Full Text] [Related]
19. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease. Kunin CM; Chesney RW; Craig WA; England AC; DeAngelis C Pediatrics; 1978 Nov; 62(5):751-60. PubMed ID: 364392 [TBL] [Abstract][Full Text] [Related]
20. [Excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with type I juvenile diabetes mellitus and of patients treated with the aminoglycoside amikacin]. Wiesmann U; Peheim E; Colombo JP Klin Wochenschr; 1989; 67 Suppl 17():40-3. PubMed ID: 2739356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]